Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Zealand Pharma
  4. Zealand Pharma — Oktober 2022

Zealand Pharma — Oktober 2022

Planlagt Fastgjort Låst Flyttet Zealand Pharma
383 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • S Offline
    S Offline
    Stroka
    wrote on sidst redigeret af
    #75

    God morgen. 🙂

    1 Reply Last reply
    0
    • P Offline
      P Offline
      ProinvestorNEWS
      wrote on sidst redigeret af
      #76

      Godmorgen 🙂

      1 Reply Last reply
      0
      • F Offline
        F Offline
        Fandel
        wrote on sidst redigeret af
        #77

        Godmorgen...

        1 Reply Last reply
        0
        • P Offline
          P Offline
          ProinvestorNEWS
          wrote on sidst redigeret af
          #78

          Tirsdagens aviser med Novo Nordisk, Schouw og Arla https://www.proinvestor.com/investornyt/886057/tirsdagens-aviser-med-novo-nordisk-schouw-og-arla

          1 Reply Last reply
          0
          • SvingtraderenS Offline
            SvingtraderenS Offline
            Svingtraderen
            wrote on sidst redigeret af
            #79

            @pensionisten det ER ekstra svært i øjblikket - prøv at se Bava - 5-6 opjusteringer i år og er ned 18% ytd. ZP er trods alt op 15% ytd. Nervøsiten styrer det meste, desværre. Vær tåmodig selvom også jeg afventer Helges Den Utålmodige Investor:)

            1 Reply Last reply
            0
            • P Offline
              P Offline
              ProinvestorNEWS
              wrote on sidst redigeret af
              #80

              Aktier/tendens: Sønderslåede aktier får opmærksomhed før grøn start https://www.proinvestor.com/investornyt/886074/aktier-tendens-sonderslaede-aktier-far-opmaerksomhed-for-gron-start

              1 Reply Last reply
              0
              • P Offline
                P Offline
                ProinvestorNEWS
                wrote on sidst redigeret af
                #81

                Zealand Pharma/Kempen: Sænker kursmål med 25 kr efter tilsvarende løft https://www.proinvestor.com/investornyt/886121/zealand-pharma-kempen-saenker-kursmal-med-25-kr-efter-tilsvarende-loft

                1 Reply Last reply
                0
                • L Offline
                  L Offline
                  Lazubia
                  wrote on sidst redigeret af
                  #82

                  Tror ikke det er skrevet herinde. En af de stoerre shortpositioner, qube research, gik i gaar under 0,5%. Der ser ioevrigt ikke ud til at der er kommet nye store short positioner efter offentliggoerelsen af glepatulide data.

                  1 Reply Last reply
                  0
                  • SvingtraderenS Offline
                    SvingtraderenS Offline
                    Svingtraderen
                    wrote on sidst redigeret af
                    #83

                    super - tak

                    1 Reply Last reply
                    0
                    • U Offline
                      U Offline
                      ungeee
                      wrote on sidst redigeret af
                      #84

                      10% udvanding

                      1 Reply Last reply
                      0
                      • exitnuE Offline
                        exitnuE Offline
                        exitnu
                        wrote on sidst redigeret af
                        #85

                        Zealand Pharma announces directed issue and private placement of approximately 4.5m new shares

                        1 Reply Last reply
                        0
                        • exitnuE Offline
                          exitnuE Offline
                          exitnu
                          wrote on sidst redigeret af
                          #86

                          Link Preview Image
                          Zealand Pharma announces directed issue and private placement of approximately 4.5m new shares

                          Company announcement – No. 43 / 2022 Zealand Pharma announces directed issue and private placement of approximately 4.5m new shares ...

                          favicon

                          GlobeNewswire News Room (www.globenewswire.com)

                          1 Reply Last reply
                          0
                          • exitnuE Offline
                            exitnuE Offline
                            exitnu
                            wrote on sidst redigeret af
                            #87

                            Zealand expects the new funds to provide cash runway until Q2 2024 and expects to advance the clinical pipeline and as such reach several potential key milestones within this time frame.

                            1 Reply Last reply
                            0
                            • exitnuE Offline
                              exitnuE Offline
                              exitnu
                              wrote on sidst redigeret af
                              #88

                              The net proceeds from the Offering are intended to:

                              • Support the Phase 3 EASE clinical program for glepaglutide and potential regulatory submission for SBS, and pursue a strong strategic partner for future commercialization

                              • Advance the clinical-stage candidates, including the obesity/metabolic disease portfolio

                              • Progress additional peptide candidates into early clinical development

                              • Strengthen the Company’s capital base and cash preparedness (general corporate purposes)

                              1 Reply Last reply
                              0
                              • exitnuE Offline
                                exitnuE Offline
                                exitnu
                                wrote on sidst redigeret af
                                #89

                                Godt med mere kapital!

                                1 Reply Last reply
                                0
                                • U Offline
                                  U Offline
                                  ungeee
                                  wrote on sidst redigeret af
                                  #90

                                  Er det kurs 166?

                                  1 Reply Last reply
                                  0
                                  • S Offline
                                    S Offline
                                    SMADK
                                    wrote on sidst redigeret af
                                    #91

                                    Mon ikke der følger meddelelser om stor-investorer med i kølvandet.

                                    1 Reply Last reply
                                    0
                                    • D Offline
                                      D Offline
                                      deleted-user
                                      wrote on sidst redigeret af
                                      #92

                                      Helt som forventet. Det kan ikke overraske. Spændende hvilken rabat der gives. Det kunne være en god entry til folket, der stod på sidelinjen og ventede på fase 3 svar, så den rabat der gives, kan hurtigt genvindes.

                                      1 Reply Last reply
                                      0
                                      • D Offline
                                        D Offline
                                        deleted-user
                                        wrote on sidst redigeret af
                                        #93

                                        @Penionisten - korrekt vurderingen. Prisen på kapital er simpelthen lavest på den måde og det tjener alle, selvom det kan irritere

                                        1 Reply Last reply
                                        0
                                        • U Offline
                                          U Offline
                                          ungeee
                                          wrote on sidst redigeret af
                                          #94

                                          Synes det skinnede tydeligt igennem at noget sådan kom under Helge Larsens interview tilbage i marts. Og det er jo bestemt ikke første gang....men altså hvis skidtet skulle være 5 mia $ værd svarer det jo så til kurs 700 🙂

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper